Cardiac medications
Pro Research Analysisby 
Searched over 200M research papers for "cardiac medications"
Common Types of Cardiac Medications and Their Uses
Cardiac medications are essential for treating and managing a wide range of heart conditions, including angina, hypertension, heart failure, arrhythmias, and high cholesterol. Commonly prescribed classes include organic nitrates, calcium-channel blockers, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists, beta-blockers, antiarrhythmic drugs, and statins. These medications work through different mechanisms to control blood pressure, improve heart function, reduce cholesterol, and manage abnormal heart rhythms .
New and Emerging Heart Failure Medications
Recent advances in heart failure treatment have led to the development of new drug classes such as angiotensin–neprilysin inhibitors, sodium–glucose cotransporter-2 inhibitors, and oral soluble guanylate cyclase stimulators. These medications have shown positive results in large clinical trials and are now recommended in the latest heart failure management guidelines. Future therapies may include drugs that target the neurohormonal system, vasodilators, anti-inflammatory agents, mitotropes (which improve heart energy metabolism), and myotropes (which enhance heart muscle contractility) .
Underutilization and Adherence to Cardiac Medications
Despite their proven benefits, many cardiac medications remain underused. For example, the use of warfarin in atrial fibrillation, beta-blockers and aspirin in coronary artery disease, and ACE inhibitors in heart failure has increased over time but still falls short of optimal levels. Greater adoption of these therapies could lead to significant public health improvements . Additionally, medication adherence is a major challenge, with factors such as self-efficacy, ability to refill prescriptions, and patient beliefs about medications influencing adherence rates. Lower adherence is often seen in outpatient settings compared to inpatient care .
Safety, Harm, and Drug Interactions
Cardiovascular medications are among the leading causes of medication-related harm, especially in older adults. They are frequently associated with preventable adverse events such as kidney injury, electrolyte imbalances, and low blood pressure. Medications for high blood pressure and abnormal heart rhythms are particularly common sources of harm. Increased awareness and careful prescribing are needed to minimize these risks .
Drug interactions are another important consideration. Herbal remedies, often perceived as safe, can interact with cardiac medications and lead to serious adverse effects. Patients may not always disclose their use of herbal products, increasing the risk of harmful interactions. There is limited scientific evidence supporting the use of herbal remedies in heart disease, and combining them with prescription drugs should be approached with caution .
Cardiac Medications in Acute and Emergency Settings
During cardiac arrest, medications such as amiodarone and lidocaine are commonly used to treat shock-refractory ventricular fibrillation or pulseless ventricular tachycardia. However, evidence on their impact on patient outcomes is mixed, and guidelines recommend their use as options rather than standard therapy. Other drugs, such as calcium, vasopressin, and glucocorticoids, have been studied, but their benefits remain uncertain. Ongoing clinical trials are investigating additional medications and administration routes to improve outcomes during cardiac arrest Lind2024Panchal2018.
Special Considerations: Ivabradine and Cardiac Glycosides
Ivabradine is a newer medication that selectively lowers heart rate without affecting blood pressure or heart contractility. It has shown benefits in patients with heart failure with reduced ejection fraction but not in those with preserved ejection fraction or acute heart conditions. Ivabradine may also help in certain heart rhythm disorders, though its use is not yet widespread .
Cardiac glycosides, such as digoxin, have been found to inhibit the binding of the SARS-CoV-2 virus to human cells in laboratory studies, suggesting a potential role in COVID-19 treatment. However, their use for this purpose is not yet established in clinical practice .
Conclusion
Cardiac medications play a vital role in managing heart disease, but challenges remain in optimizing their use, ensuring patient adherence, and minimizing harm. New drug classes and ongoing research continue to improve treatment options, while careful attention to drug interactions and patient safety is essential, especially in older adults and those using herbal remedies. Ongoing education and guideline updates are key to maximizing the benefits and minimizing the risks of cardiac medications.
Sources and full results
Most relevant research papers on this topic